RxA’s Trusted Partners in Health
Fall Professional Development Conference

Liver disease is becoming increasingly common in Canada. This concurrent presentation will explore one dimension of liver disease, specifically, cirrhosis.  Liver cirrhosis is commonly encountered in multiple pharmacy practice settings such as in the community, inpatient acute care practice and outpatient clinics. Pharmacists can play a vital role in supporting patients in the management of this condition.

This presentation will provide an overview of liver cirrhosis in the adult patient population, discuss the major complications of liver cirrhosis with a particular focus on ascites and hepatic encephalopathy, and explore a relevant patient-case scenario encountered in practice.

In this concurrent session, Clinical Associate Professor Tara Leslie will describe the unique mechanism of action of immune checkpoint inhibitor (ICI) therapy for cancer, appreciating the revolutionary efficacy of ICIs in some previously difficult-to-treat cancers. She will explain how to recognize the signs and symptoms of common immune-mediated adverse effects (IMAE) that may be seen in the community and discuss how to provide supportive care to ambulatory cancer patients experiencing IMAE. Finally, Tara will identify relevant interactions with ICI therapies and common community pharmacy medications (drug-drug) and disease states (drug-disease).

In this concurrent presentation, Christina will touch on the most common travel-related risks and how to effectively educate travellers on minimizing those risks. Immunization schedules and boosters for the frequently recommended vaccines will be discussed using CATMAT guidelines and evidence-based practice. Christina will also discuss the limitations pharmacists may have or experience in providing optimal pre-travel counselling, and how to overcome those barriers.

Liver disease is becoming increasingly common in Canada. This concurrent presentation will explore one dimension of liver disease, specifically, cirrhosis.  Liver cirrhosis is commonly encountered in multiple pharmacy practice settings such as in the community, inpatient acute care practice and outpatient clinics. Pharmacists can play a vital role in supporting patients in the management of this condition.

This presentation will provide an overview of liver cirrhosis in the adult patient population, discuss the major complications of liver cirrhosis with a particular focus on ascites and hepatic encephalopathy, and explore a relevant patient-case scenario encountered in practice.

In this concurrent session, Clinical Associate Professor Tara Leslie will describe the unique mechanism of action of immune checkpoint inhibitor (ICI) therapy for cancer, appreciating the revolutionary efficacy of ICIs in some previously difficult-to-treat cancers. She will explain how to recognize the signs and symptoms of common immune-mediated adverse effects (IMAE) that may be seen in the community and discuss how to provide supportive care to ambulatory cancer patients experiencing IMAE. Finally, Tara will identify relevant interactions with ICI therapies and common community pharmacy medications (drug-drug) and disease states (drug-disease).

In this concurrent presentation, Christina will touch on the most common travel-related risks and how to effectively educate travellers on minimizing those risks. Immunization schedules and boosters for the frequently recommended vaccines will be discussed using CATMAT guidelines and evidence-based practice. Christina will also discuss the limitations pharmacists may have or experience in providing optimal pre-travel counselling, and how to overcome those barriers.